Sven Stirnweiss

Title: Sven Stirnweiss: Innovator in Pharmaceutical Chemistry

Introduction

Sven Stirnweiss is a notable inventor based in Fuerth, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of crystalline solvated forms of complex compounds. His work is essential for advancing medical treatments and improving drug formulations.

Latest Patents

Sven Stirnweiss holds a patent for a compound titled "Crystalline solvated forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea." This patent encompasses not only the crystalline forms but also methods for their production, pharmaceutical compositions, and treatment applications involving these compounds.

Career Highlights

Sven Stirnweiss is associated with Sumitomo Pharma Co., Ltd., where he has been instrumental in research and development. His innovative approach has led to advancements in drug formulation and therapeutic applications, showcasing his expertise in the pharmaceutical industry.

Collaborations

Sven has collaborated with notable colleagues, including Carsten Jagusch and Christian Klaus Herz. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Sven Stirnweiss is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact medical treatments significantly. His contributions, particularly in the area of crystalline solvated forms, demonstrate his commitment to innovation and excellence in the field.